CRM

$229.170.75%-1.73

Pre-mercato: 229.50+0.33 +0.14%

Salesforce Inc (CRM)

Date: O: H: L: C: Vol:

Precedente Chiudi:

$230.90

Aprire:

$231.34

Volume 24 ore:

7,894,797

Volume relativo:

1.10

Capitalizzazione di mercato:

$188.61B

Reddito:

$42.83B

Utile/perdita netta:

$8.02B

Rapporto P/E:

26.53

EPS:

$8.64

Flusso di cassa netto:

$14.66B

1W Prestazione:

-7.45%

1M Prestazione:

-2.35%

6M Prestazione:

+24.67%

1Y Prestazione:

-12.00%

Intervallo 1D:

$0.00$0.00

Intervallo di 1 settimana:

$225.04$248.08

Portata 52W:

$146.32$269.11

Profilo aziendale di Salesforce Inc (CRM)

Nome

Salesforce Inc

Settore

Technology

Industria

Software - Application

Telefono

415-901-7000

Indirizzo

SALESFORCE TOWER, SAN FRANCISCO, USA

Dipendente

83,334

@salesforceapac

Prossima data di guadagno

2026-12-02

Ultimi documenti SEC

SEC

Discussioni di CRM su X

Confronta CRM con SAP, SHOP, UBER, ADP

Azioni	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CRM Salesforce Inc	$188.61B	$42.83B	$8.02B	$14.66B	$8.64
SAP Sap Se Adr	$271.26B	$43.29B	$8.86B	$9.44B	$7.41
SHOP Shopify Inc	$202.63B	$12.37B	$1.33B	$2.12B	$1.02
UBER Uber Technologies Inc	$133.28B	$53.69B	$8.60B	$9.80B	$4.01
ADP Automatic Data Processing Inc	$116.24B	$21.60B	$4.35B	$4.84B	$10.73

Salesforce Inc Azioni (CRM) Upgrade e downgrade

Data	Azione	Analista	Modifica della valutazione
2026-10-12	Aggiornamento	BofA Securities	Underperform → Buy
2026-09-17	Reiterato	BMO Capital Markets	Outperform
2026-08-27	Reiterato	BMO Capital Markets	Outperform
2026-08-27	Reiterato	Monness Crespi & Hardt	Buy
2026-08-13	Resumed	JP Morgan	Overweight
2026-08-13	Reiterato	Monness Crespi & Hardt	Buy
2026-08-05	Aggiornamento	Erste Group	Hold → Buy
2026-07-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2026-07-20	Iniziato	CLSA	Hold
2026-07-09	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
2026-07-01	Aggiornamento	Guggenheim	Neutral → Buy
2026-06-18	Aggiornamento	Monness Crespi & Hardt	Neutral → Buy
2026-05-18	Resumed	BofA Securities	Underperform
2026-02-26	Reiterato	BMO Capital Markets	Outperform
2026-02-20	Reiterato	BMO Capital Markets	Outperform
2026-01-12	Resumed	Goldman	Buy
2025-12-04	Reiterato	BMO Capital Markets	Outperform
2025-10-14	Downgrade	Northland Capital	Outperform → Market Perform
2025-09-04	Reiterato	BMO Capital Markets	Outperform
2025-08-26	Reiterato	Oppenheimer	Outperform
2025-08-15	Aggiornamento	DA Davidson	Underperform → Neutral
2025-06-05	Downgrade	Erste Group	Buy → Hold
2025-06-03	Iniziato	Cantor Fitzgerald	Overweight
2025-05-29	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2025-05-27	Reiterato	BMO Capital Markets	Outperform
2025-04-21	Downgrade	DA Davidson	Neutral → Underperform
2025-03-19	Iniziato	Stephens	Equal-Weight
2025-02-27	Reiterato	BMO Capital Markets	Outperform
2025-02-19	Iniziato	Redburn Atlantic	Buy
2025-01-17	Aggiornamento	TD Cowen	Hold → Buy
2025-01-06	Downgrade	Guggenheim	Neutral → Sell
2024-12-13	Aggiornamento	KeyBanc Capital Markets	Sector Weight → Overweight
2024-12-12	Iniziato	Macquarie	Neutral
2024-12-04	Reiterato	BMO Capital Markets	Outperform
2024-11-19	Iniziato	Scotiabank	Sector Outperform
2024-11-15	Reiterato	BMO Capital Markets	Outperform
2024-10-02	Aggiornamento	Northland Capital	Market Perform → Outperform
2024-09-24	Aggiornamento	Piper Sandler	Neutral → Overweight
2024-08-29	Reiterato	BMO Capital Markets	Outperform
2024-05-30	Reiterato	Oppenheimer	Outperform
2024-03-21	Iniziato	KeyBanc Capital Markets	Sector Weight
2024-01-11	Aggiornamento	Robert W. Baird	Neutral → Outperform
2023-12-21	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2023-12-20	Downgrade	Wells Fargo	Overweight → Equal Weight
2023-12-18	Aggiornamento	Wolfe Research	Peer Perform → Outperform
2023-11-30	Reiterato	BMO Capital Markets	Outperform
2023-11-30	Reiterato	Needham	Buy
2023-11-30	Reiterato	Oppenheimer	Outperform
2023-10-23	Downgrade	Piper Sandler	Overweight → Neutral
2023-09-15	Iniziato	HSBC Securities	Buy
2023-07-31	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2023-06-01	Downgrade	Societe Generale	Buy → Hold
2023-03-02	Aggiornamento	Needham	Hold → Buy
2023-01-20	Downgrade	Cowen	Outperform → Market Perform
2023-01-18	Iniziato	DA Davidson	Neutral
2023-01-13	Downgrade	Atlantic Equities	Overweight → Neutral
2023-01-11	Downgrade	Bernstein	Mkt Perform → Underperform
2022-12-08	Downgrade	Robert W. Baird	Outperform → Neutral
2022-12-02	Downgrade	Wolfe Research	Outperform → Peer Perform
2022-11-17	Downgrade	Monness Crespi & Hardt	Buy → Neutral
2022-11-02	Resumed	Macquarie	Outperform
2022-10-17	Iniziato	Northland Capital	Market Perform
2022-09-28	Downgrade	Cleveland Research	Buy → Neutral
2022-09-02	Aggiornamento	Guggenheim	Sell → Neutral
2022-08-12	Iniziato	Guggenheim	Sell
2022-05-18	Aggiornamento	ROTH Capital	Neutral → Buy
2022-03-02	Reiterato	BMO Capital Markets	Outperform
2022-03-02	Reiterato	BofA Securities	Buy
2022-03-02	Reiterato	Canaccord Genuity	Buy
2022-03-02	Reiterato	Piper Sandler	Overweight
2022-03-02	Reiterato	Raymond James	Strong Buy
2022-03-02	Reiterato	Stifel	Buy
2022-03-02	Reiterato	UBS	Neutral
2022-03-02	Reiterato	Wedbush	Outperform
2022-01-05	Downgrade	UBS	Buy → Neutral
2021-11-22	Resumed	Atlantic Equities	Overweight
2021-11-16	Iniziato	Credit Suisse	Outperform
2021-11-02	Iniziato	Deutsche Bank	Buy
2021-09-24	Reiterato	Monness Crespi & Hardt	Buy
2021-09-24	Aggiornamento	Piper Sandler	Neutral → Overweight
2021-09-20	Iniziato	Wells Fargo	Overweight
2021-08-26	Reiterato	Barclays	Overweight
2021-08-26	Reiterato	Bernstein	Mkt Perform
2021-08-26	Reiterato	BofA Securities	Buy
2021-08-26	Reiterato	Canaccord Genuity	Buy
2021-08-26	Reiterato	Citigroup	Neutral
2021-08-26	Reiterato	Cowen	Outperform
2021-08-26	Reiterato	Credit Suisse	Outperform
2021-08-26	Reiterato	FBN Securities	Outperform
2021-08-26	Reiterato	Mizuho	Buy
2021-08-26	Reiterato	Monness Crespi & Hardt	Buy
2021-08-26	Reiterato	Oppenheimer	Outperform
2021-08-26	Reiterato	Piper Sandler	Neutral
2021-08-26	Reiterato	Stifel	Buy
2021-08-26	Reiterato	UBS	Buy
2021-07-16	Resumed	Stifel	Buy
2021-06-28	Iniziato	Redburn	Buy
2021-05-28	Reiterato	Monness Crespi & Hardt	Buy
2021-05-19	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2021-04-23	Iniziato	Wolfe Research	Outperform
2021-04-05	Resumed	Credit Suisse	Outperform
2021-03-16	Resumed	Credit Suisse	Outperform
2021-01-25	Aggiornamento	Loop Capital	Sell → Hold
2021-01-22	Iniziato	Goldman	Buy
2021-01-11	Downgrade	Piper Sandler	Overweight → Neutral
2020-12-16	Resumed	BofA Securities	Buy
2020-12-02	Downgrade	Citigroup	Buy → Neutral
2020-11-24	Iniziato	KeyBanc Capital Markets	Overweight
2020-11-12	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2020-10-14	Resumed	UBS	Buy
2020-08-26	Reiterato	Barclays	Overweight
2020-08-26	Reiterato	Citigroup	Buy
2020-08-26	Reiterato	Cowen	Outperform
2020-08-26	Reiterato	Credit Suisse	Outperform
2020-08-26	Reiterato	JMP Securities	Mkt Outperform
2020-08-26	Reiterato	Jefferies	Buy
2020-08-26	Reiterato	Mizuho	Buy
2020-08-26	Reiterato	Monness Crespi & Hardt	Buy
2020-08-26	Reiterato	RBC Capital Mkts	Outperform
2020-08-26	Reiterato	Raymond James	Strong Buy
2020-08-26	Reiterato	Stifel	Buy
2020-08-26	Reiterato	Truist	Buy
2020-08-26	Reiterato	Wedbush	Outperform
2020-08-24	Reiterato	Barclays	Overweight

Salesforce Inc Azioni (CRM) Dati Finanziari

Periodo	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Data di fine periodo	-	2025-01-31	2023-01-31	2022-01-31	2021-01-31
Revenue USD (M)	41,525.00	34,857.00	31,352.00	26,492.00	21,252.00
Cost of revenue USD (M)	9,270.00	8,541.00	8,360.00	7,026.00	5,438.00
Gross profit USD (M)	32,255.00	26,316.00	22,992.00	19,466.00	15,814.00
Research and development USD (M)	5,993.00	4,906.00	5,055.00	4,465.00	3,598.00
Operating expenses USD (M)	23,924.00	21,305.00	21,962.00	18,918.00	15,359.00
Operating income USD (M)	8,331.00	5,011.00	1,030.00	548.00	455.00
Income before tax USD (M)	9,520.00	4,950.00	660.00	1,532.00	2,561.00
Income tax expense USD (M)	2,063.00	814.00	452.00	88.00	-1,511.00
Net income USD (M)	7,457.00	4,136.00	208.00	1,444.00	4,072.00
Basic EPS USD/shares	7.85	4.25	0.21	1.51	4.48
Diluted EPS USD/shares	7.80	4.20	0.21	1.48	4.38
Basic weighted shares shares (M)	950.00	974.00	992.00	955.00	908.00
Diluted weighted shares shares (M)	956.00	984.00	997.00	974.00	930.00

Salesforce Inc Azioni (CRM) insider trading

Milano MiguelSep 22 '26
President and COO
Transazione
Option Exercise
Costo
$0.00
#Azioni
2,541
Valore ($)
0
#Azioni Totale
34,360
Harris ParkerSep 22 '26
Co-Founder
Transazione
Option Exercise
Costo
$0.00
#Azioni
2,541
Valore ($)
0
#Azioni Totale
165,199
Washington Robin LSep 22 '26
President and COFO
Transazione
Option Exercise
Costo
$0.00
#Azioni
1,831
Valore ($)
0
#Azioni Totale
50,658
Niles SabastianSep 22 '26
President and CLO
Transazione
Option Exercise
Costo
$0.00
#Azioni
2,032
Valore ($)
0
#Azioni Totale
19,634
Kirk David BlairSep 18 '26
Director
Transazione
Buy
Costo
$239.33
#Azioni
4,176
Valore ($)
999,451
#Azioni Totale
18,748
Conway CraigSep 04 '26
Director
Transazione
Sale
Costo
$260.61
#Azioni
4,500
Valore ($)
1,172,746
#Azioni Totale
5,437
CRAIG CONWAYSep 04 '26
Officer
Transazione
Proposed Sale
Costo
$260.61
#Azioni
4,500
Valore ($)
1,172,746
#Azioni Totale
0
SUNDEEP REDDYAug 27 '26
Officer
Transazione
Proposed Sale
Costo
$233.70
#Azioni
5,250
Valore ($)
1,226,925
#Azioni Totale
0
MUNOZ OSCARAug 22 '26
Director
Transazione
Option Exercise
Costo
$0.00
#Azioni
441
Valore ($)
0
#Azioni Totale
13,990
KROES NEELIEAug 22 '26
Director
Transazione
Option Exercise
Costo
$0.00
#Azioni
441
Valore ($)
0
#Azioni Totale
8,557

Commercio interno	Relazione	Data	Transazione	Costo	#Azioni	Valore ($)	#Azioni Totale
Milano Miguel	President and COO	Sep 22 '26	Option Exercise	$0.00	2,541	0	34,360
Harris Parker	Co-Founder	Sep 22 '26	Option Exercise	$0.00	2,541	0	165,199
Washington Robin L	President and COFO	Sep 22 '26	Option Exercise	$0.00	1,831	0	50,658
Niles Sabastian	President and CLO	Sep 22 '26	Option Exercise	$0.00	2,032	0	19,634
Kirk David Blair	Director	Sep 18 '26	Buy	$239.33	4,176	999,451	18,748
Conway Craig	Director	Sep 04 '26	Sale	$260.61	4,500	1,172,746	5,437
CRAIG CONWAY	Officer	Sep 04 '26	Proposed Sale	$260.61	4,500	1,172,746	0
SUNDEEP REDDY	Officer	Aug 27 '26	Proposed Sale	$233.70	5,250	1,226,925	0
MUNOZ OSCAR	Director	Aug 22 '26	Option Exercise	$0.00	441	0	13,990
KROES NEELIE	Director	Aug 22 '26	Option Exercise	$0.00	441	0	8,557

Salesforce Inc Borsa (CRM) Ultime notizie

Oct 31, 2026

Presentations.AI Expands Google Docs to PowerPoint, Word and PDF to Slides Conversion, and Launches a Free Chrome Extension to Create Slides With AI From Any Webpage - GlobeNewswire Inc.

Oct 31, 2026

Oct 30, 2026

Axon Enterprise vs. ServiceNow: Which Industrials Stock Is a Better Buy in 2026? - The Motley Fool

Oct 30, 2026

Axon Enterprise vs. DocuSign: Which Industrials Stock Is a Better Buy in 2026? - The Motley Fool

Oct 30, 2026

Adobe Drops 29% YTD: Should You Buy, Sell or Hold the Stock? - Zacks Investment Research

Oct 30, 2026

Why ServiceNow Stock Plunged This Week - The Motley Fool

Oct 30, 2026

Oct 29, 2026

Stock Market Today, Oct. 29: Amazon Falls on Q3 Earnings Report and Capex Concerns - The Motley Fool

Oct 29, 2026

Founder-Led Giants Redefining Technology and Global Market Growth - Zacks Investment Research

Oct 29, 2026

Salesforce Inc Stock (CRM) Moved Down by 4.46% on Oct 29: What Signal Does It Send? - TradingKey

Oct 29, 2026

Why Is Salesforce Stock Falling on Thursday? - Benzinga

Oct 29, 2026

ServiceNow's Debt and Interest Costs Jump: Is Cash Flow Enough? - Zacks Investment Research

Oct 29, 2026

3,006 Salesforce Inc. $CRM Shares Sold by Simplify Asset Management Inc. - MarketBeat

Oct 29, 2026